Rankings
▼
Calendar
XOMAP Q4 2018 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena
XOMAP
XOMA Corporation
$311M
Q4 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
-68.5% YoY
Gross Profit
$1M
85.9% margin
Operating Income
-$3M
-203.1% margin
Net Income
-$3M
-178.8% margin
EPS (Diluted)
$-0.27
QoQ Revenue Growth
+88.1%
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$3M
Stock-Based Comp.
$869,000
Balance Sheet
Total Assets
$64M
Total Liabilities
$45M
Stockholders' Equity
$19M
Cash & Equivalents
$46M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2M
$5M
-68.5%
Gross Profit
$1M
$5M
-69.2%
Operating Income
-$3M
-$2M
-70.2%
Net Income
-$3M
-$1M
-128.5%
← FY 2018
All Quarters
Q1 2019 →